X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Fulford India with MYLAN INC. - US - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs MYLAN (US) - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 FULFORD INDIA   MYLAN
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
MYLAN
Dec-14
FULFORD INDIA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs9423,830-   
Low Rs4502,699-   
Sales per share (Unadj.) Rs691.41,311.3-  
Earnings per share (Unadj.) Rs11.5158.0-  
Cash flow per share (Unadj.) Rs15.4254.3-  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.30-  
Book value per share (Unadj.) Rs380.0651.9-  
Shares outstanding (eoy) m3.90378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x1.02.5 40.4%   
Avg P/E ratio x60.720.7 293.8%  
P/CF ratio (eoy) x45.312.8 352.9%  
Price / Book Value ratio x1.85.0 36.6%  
Dividend payout %17.40-   
Avg Mkt Cap Rs m2,7141,235,346 0.2%   
No. of employees `0000.425.0 1.8%   
Total wages/salary Rs m5050-   
Avg. sales/employee Rs Th6,073.019,846.6 30.6%   
Avg. wages/employee Rs Th1,137.40-   
Avg. net profit/employee Rs Th100.72,390.8 4.2%   
INCOME DATA
Net Sales Rs m2,696496,164 0.5%  
Other income Rs m125-2,892 -4.3%   
Total revenues Rs m2,822493,272 0.6%   
Gross profit Rs m-46123,398 -0.0%  
Depreciation Rs m1536,441 0.0%   
Interest Rs m1021,402 0.0%   
Profit before tax Rs m5462,663 0.1%   
Minority Interest Rs m0-257 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m102,635 0.4%   
Profit after tax Rs m4559,771 0.1%  
Gross profit margin %-1.724.9 -6.9%  
Effective tax rate %17.74.2 420.4%   
Net profit margin %1.712.0 13.8%  
BALANCE SHEET DATA
Current assets Rs m1,738436,194 0.4%   
Current liabilities Rs m545341,017 0.2%   
Net working cap to sales %44.319.2 230.8%  
Current ratio x3.21.3 249.5%  
Inventory Days Days4878 62.1%  
Debtors Days Days4107 4.0%  
Net fixed assets Rs m12114,786 0.0%   
Share capital Rs m3917,546 0.2%   
"Free" reserves Rs m1,4430-   
Net worth Rs m1,482246,643 0.6%   
Long term debt Rs m0368,460 0.0%   
Total assets Rs m2,077993,454 0.2%  
Interest coverage x6.73.9 171.0%   
Debt to equity ratio x01.5 0.0%  
Sales to assets ratio x1.30.5 260.0%   
Return on assets %2.68.2 31.9%  
Return on equity %3.024.2 12.4%  
Return on capital %4.313.6 31.6%  
Exports to sales %00-   
Imports to sales %24.50-   
Net fx Rs m-6560-   
CASH FLOW
From Operations Rs m9065,221 0.1%  
From Investments Rs m105-51,435 -0.2%  
From Financial Activity Rs m-14-17,186 0.1%  
Net Cashflow Rs m181-3,400 -5.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 64.27 Rs / USD

Compare FULFORD INDIA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare FULFORD INDIA With: STERLING BIOTECH  NOVARTIS  SANOFI INDIA  STRIDES SHASUN LTD  UNICHEM LAB  



Today's Market

Sensex Opens Marginally Down; Tata Steel Top Loser(09:30 am)

Asian stocks rose in morning trade on Monday, after the US's S&P 500 extended its winning streak on Friday to six days. Markets in the Greater China region remain closed for the Lunar New Year holiday.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 5-YR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS